CN Stock MarketDetailed Quotes

688091 Shanghai Yizhong Pharmaceutical

Watchlist
  • 40.27
  • +0.72+1.82%
Market Closed Apr 26 15:00 CST
6.37BMarket Cap39.44P/E (TTM)

Shanghai Yizhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Total operating revenue
52.68%360.25M
67.87%279.2M
178.88%200.43M
169.06%92.4M
5,686.75%235.96M
166.32M
71.87M
34.34M
4.08M
Operating revenue
52.68%360.25M
67.87%279.2M
178.88%200.43M
169.06%92.4M
5,686.75%235.96M
--166.32M
--71.87M
--34.34M
--4.08M
----
Total operating cost
58.58%168.3M
72.00%123.69M
326.22%76.7M
180.22%26.74M
323.59%106.13M
224.36%71.91M
36.96%18M
59.93%9.54M
-9.78%25.05M
11.21%22.17M
Operating cost
38.99%23.59M
60.37%18.91M
150.76%13.88M
206.46%7.1M
5,636.79%16.97M
--11.79M
--5.53M
--2.32M
--295.81K
----
Operating tax surcharges
78.03%1.61M
129.07%1.25M
333.09%891.67K
6,969.03%419.94K
3,458.89%904.66K
2,511.81%543.61K
1,142.76%205.89K
-41.81%5.94K
-34.23%25.42K
-39.86%20.81K
Operating expense
19.77%106.63M
32.45%78.78M
325.22%48.53M
209.77%14.79M
3,740.98%89.03M
11,941.78%59.47M
--11.41M
--4.77M
--2.32M
--493.91K
Administration expense
325.92%40.94M
327.64%28.28M
316.39%17.79M
284.55%8.55M
-35.81%9.61M
-44.89%6.61M
-28.92%4.27M
-29.42%2.22M
23.82%14.97M
36.97%12M
Financial expense
-46.99%-26.92M
-79.64%-20.23M
-124.06%-13.37M
-444.49%-6.72M
-215.85%-18.32M
-243.51%-11.26M
-203.36%-5.97M
-19.17%-1.23M
-156.98%-5.8M
-145.70%-3.28M
-Interest expense (Financial expense)
3,248.37%269.96K
-56.28%214.88K
-14.40%119.44K
171.09%66.74K
-101.46%-8.57K
18.02%491.43K
-39.28%139.54K
-260.41%-93.88K
4,709.92%588.86K
--416.38K
-Interest Income (Financial expense)
-48.72%-27.25M
-74.24%-20.49M
-121.51%-13.54M
-493.67%-6.79M
-186.11%-18.32M
-217.23%-11.76M
-177.17%-6.11M
-4.33%-1.14M
-180.20%-6.4M
-175.92%-3.71M
Research and development
183.26%22.45M
251.84%16.71M
254.02%8.99M
78.71%2.6M
-40.14%7.93M
-63.29%4.75M
-72.04%2.54M
-62.10%1.46M
-26.01%13.24M
3.68%12.94M
Credit Impairment Loss
-167.23%-5.43M
-213.97%-5.01M
-174.77%-4.09M
-148.26%-1.77M
-840.77%-2.03M
---1.6M
---1.49M
---713.31K
---216.03K
----
Asset Impairment Loss
---36.75K
----
----
----
----
----
----
----
----
----
Other net revenue
Fair value change income
-53.35%418.49K
-23.83%880.27K
104.35%1.7M
327.48%872.05K
-72.39%897.09K
1,425.36%1.16M
1,983.89%832.34K
63.52%204K
2,903.53%3.25M
75.99%-87.2K
Invest income
-40.81%7.1M
-48.06%4.95M
-67.29%2.32M
-79.29%1.1M
447.22%12M
980.05%9.54M
1,535.96%7.1M
4,695.32%5.32M
-36.10%2.19M
-74.38%883.01K
Other revenue
-86.74%1.45M
-39.13%704.79K
13.89%491.31K
27.25%279.83K
68.43%10.9M
77.87%1.16M
-1.70%431.38K
-2.70%219.9K
170.80%6.47M
-70.10%650.97K
Operating profit
28.94%195.45M
50.04%157.04M
104.38%124.15M
121.73%66.15M
1,733.23%151.59M
605.06%104.67M
596.87%60.75M
641.97%29.83M
57.50%-9.28M
-41.21%-20.72M
Add:Non operating Income
300.00%2.4K
300.00%2.4K
--2.4K
--2.4K
--600
-99.90%600
----
----
----
--600.1K
Less:Non operating expense
322.23%8.56M
306.66%5.77M
329.06%3.1M
--1.83M
--2.03M
--1.42M
--722.68K
----
----
----
Total profit
24.97%186.9M
46.52%151.28M
101.67%121.06M
115.62%64.32M
1,711.40%149.56M
613.07%103.25M
590.96%60.03M
641.97%29.83M
57.52%-9.28M
-37.06%-20.12M
Less:Income tax cost
277.93%25.35M
2,351.12%20.65M
1,877.37%16.95M
1,118.76%9.3M
226.91%6.71M
---917.41K
---953.48K
---912.66K
---5.28M
----
Net profit
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
FLtoP142.85M
FLtoP104.17M
FLtoP60.98M
FLtoP30.74M
FPtoL-4M
FPtoL-20.12M
Net profit from continuing operation
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
658.55%30.74M
81.70%-4M
---20.12M
Net profit of parent company owners
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
658.55%30.74M
81.70%-4M
-37.06%-20.12M
Earning per share
Basic earning per share
3.03%1.02
-15.31%0.83
13.79%0.66
31.03%0.38
2,080.00%0.99
508.33%0.98
486.67%0.58
514.29%0.29
82.14%-0.05
-26.32%-0.24
Diluted earning per share
3.03%1.02
-15.31%0.83
13.79%0.66
31.03%0.38
2,080.00%0.99
508.33%0.98
486.67%0.58
514.29%0.29
82.14%-0.05
-26.32%-0.24
Other composite income
Total composite income
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
658.55%30.74M
81.70%-4M
-37.06%-20.12M
Total composite income of parent company owners
13.09%161.55M
25.40%130.62M
70.73%104.11M
78.98%55.03M
3,674.01%142.85M
617.63%104.17M
598.76%60.98M
658.55%30.74M
81.70%-4M
-37.06%-20.12M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
Unqualified opinion
--
--
--
--
--
Auditor
--
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Total operating revenue 52.68%360.25M67.87%279.2M178.88%200.43M169.06%92.4M5,686.75%235.96M166.32M71.87M34.34M4.08M
Operating revenue 52.68%360.25M67.87%279.2M178.88%200.43M169.06%92.4M5,686.75%235.96M--166.32M--71.87M--34.34M--4.08M----
Total operating cost 58.58%168.3M72.00%123.69M326.22%76.7M180.22%26.74M323.59%106.13M224.36%71.91M36.96%18M59.93%9.54M-9.78%25.05M11.21%22.17M
Operating cost 38.99%23.59M60.37%18.91M150.76%13.88M206.46%7.1M5,636.79%16.97M--11.79M--5.53M--2.32M--295.81K----
Operating tax surcharges 78.03%1.61M129.07%1.25M333.09%891.67K6,969.03%419.94K3,458.89%904.66K2,511.81%543.61K1,142.76%205.89K-41.81%5.94K-34.23%25.42K-39.86%20.81K
Operating expense 19.77%106.63M32.45%78.78M325.22%48.53M209.77%14.79M3,740.98%89.03M11,941.78%59.47M--11.41M--4.77M--2.32M--493.91K
Administration expense 325.92%40.94M327.64%28.28M316.39%17.79M284.55%8.55M-35.81%9.61M-44.89%6.61M-28.92%4.27M-29.42%2.22M23.82%14.97M36.97%12M
Financial expense -46.99%-26.92M-79.64%-20.23M-124.06%-13.37M-444.49%-6.72M-215.85%-18.32M-243.51%-11.26M-203.36%-5.97M-19.17%-1.23M-156.98%-5.8M-145.70%-3.28M
-Interest expense (Financial expense) 3,248.37%269.96K-56.28%214.88K-14.40%119.44K171.09%66.74K-101.46%-8.57K18.02%491.43K-39.28%139.54K-260.41%-93.88K4,709.92%588.86K--416.38K
-Interest Income (Financial expense) -48.72%-27.25M-74.24%-20.49M-121.51%-13.54M-493.67%-6.79M-186.11%-18.32M-217.23%-11.76M-177.17%-6.11M-4.33%-1.14M-180.20%-6.4M-175.92%-3.71M
Research and development 183.26%22.45M251.84%16.71M254.02%8.99M78.71%2.6M-40.14%7.93M-63.29%4.75M-72.04%2.54M-62.10%1.46M-26.01%13.24M3.68%12.94M
Credit Impairment Loss -167.23%-5.43M-213.97%-5.01M-174.77%-4.09M-148.26%-1.77M-840.77%-2.03M---1.6M---1.49M---713.31K---216.03K----
Asset Impairment Loss ---36.75K------------------------------------
Other net revenue
Fair value change income -53.35%418.49K-23.83%880.27K104.35%1.7M327.48%872.05K-72.39%897.09K1,425.36%1.16M1,983.89%832.34K63.52%204K2,903.53%3.25M75.99%-87.2K
Invest income -40.81%7.1M-48.06%4.95M-67.29%2.32M-79.29%1.1M447.22%12M980.05%9.54M1,535.96%7.1M4,695.32%5.32M-36.10%2.19M-74.38%883.01K
Other revenue -86.74%1.45M-39.13%704.79K13.89%491.31K27.25%279.83K68.43%10.9M77.87%1.16M-1.70%431.38K-2.70%219.9K170.80%6.47M-70.10%650.97K
Operating profit 28.94%195.45M50.04%157.04M104.38%124.15M121.73%66.15M1,733.23%151.59M605.06%104.67M596.87%60.75M641.97%29.83M57.50%-9.28M-41.21%-20.72M
Add:Non operating Income 300.00%2.4K300.00%2.4K--2.4K--2.4K--600-99.90%600--------------600.1K
Less:Non operating expense 322.23%8.56M306.66%5.77M329.06%3.1M--1.83M--2.03M--1.42M--722.68K------------
Total profit 24.97%186.9M46.52%151.28M101.67%121.06M115.62%64.32M1,711.40%149.56M613.07%103.25M590.96%60.03M641.97%29.83M57.52%-9.28M-37.06%-20.12M
Less:Income tax cost 277.93%25.35M2,351.12%20.65M1,877.37%16.95M1,118.76%9.3M226.91%6.71M---917.41K---953.48K---912.66K---5.28M----
Net profit 13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03MFLtoP142.85MFLtoP104.17MFLtoP60.98MFLtoP30.74MFPtoL-4MFPtoL-20.12M
Net profit from continuing operation 13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M658.55%30.74M81.70%-4M---20.12M
Net profit of parent company owners 13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M658.55%30.74M81.70%-4M-37.06%-20.12M
Earning per share
Basic earning per share 3.03%1.02-15.31%0.8313.79%0.6631.03%0.382,080.00%0.99508.33%0.98486.67%0.58514.29%0.2982.14%-0.05-26.32%-0.24
Diluted earning per share 3.03%1.02-15.31%0.8313.79%0.6631.03%0.382,080.00%0.99508.33%0.98486.67%0.58514.29%0.2982.14%-0.05-26.32%-0.24
Other composite income
Total composite income 13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M658.55%30.74M81.70%-4M-37.06%-20.12M
Total composite income of parent company owners 13.09%161.55M25.40%130.62M70.73%104.11M78.98%55.03M3,674.01%142.85M617.63%104.17M598.76%60.98M658.55%30.74M81.70%-4M-37.06%-20.12M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------Unqualified opinion----------
Auditor --------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg